WHO Prequalifies Serum Institute's Cervavac HPV Vaccine
The story in brief
The World Health Organization prequalified Serum Institute of India's HPV vaccine Cervavac, making it eligible for UN procurement. This marks a major milestone for India's vaccine development and is expected to improve public health outcomes in Pune and other regions. Serum Institute may now scale up production to meet global demand.